Visudyne
Payments companies reported to CMS as associated with Visudyne. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Visudyne, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Visudyne
These are the largest totals companies reported as associated with Visudyne. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jay Chhablani | Pittsburgh, PA | Retina Specialist | $7,259.49 |
| Majda Hadziahmetovic | Durham, NC | Ophthalmology | $7,063.46 |
| Sunil Srivastava | Cleveland, OH | Ophthalmology | $6,000.00 |
| Ramon Lee | Royal Oak, MI | Retina Specialist | $2,000.00 |
| Kent Anderson | San Antonio, TX | Ophthalmology | $1,500.00 |
| Jennifer Lim | Chicago, IL | Ophthalmology | $1,000.00 |
| Ann Marie Lobo-Chan | Chicago, IL | Ophthalmology | $750.00 |
| Jordana Fein | Manassas, VA | Retina Specialist | $553.23 |
| Mark Barakat | Scottsdale, AZ | Ophthalmology | $274.90 |
| Rolake Alabi | Austin, TX | Ophthalmology | $255.82 |
Prescribed Visudyne?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.